Voyager Therapeutics VYGR Stock
Voyager Therapeutics Price Chart
Voyager Therapeutics VYGR Financial and Trading Overview
| Voyager Therapeutics stock price | 3.53 USD |
| Previous Close | 12.93 USD |
| Open | 13.1 USD |
| Bid | 0 USD x 900 |
| Ask | 0 USD x 900 |
| Day's Range | 12.79 - 13.29 USD |
| 52 Week Range | 4.77 - 14.34 USD |
| Volume | 401.65K USD |
| Avg. Volume | 491.07K USD |
| Market Cap | 573.36M USD |
| Beta (5Y Monthly) | 1.097887 |
| PE Ratio (TTM) | 5.879464 |
| EPS (TTM) | -1.13 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 13.67 USD |
VYGR Valuation Measures
| Enterprise Value | 312.04M USD |
| Trailing P/E | 5.879464 |
| Forward P/E | -6.2122645 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3.0061703 |
| Price/Book (mrq) | 2.6366367 |
| Enterprise Value/Revenue | 1.636 |
| Enterprise Value/EBITDA | 3.189 |
Trading Information
Voyager Therapeutics Stock Price History
| Beta (5Y Monthly) | 1.097887 |
| 52-Week Change | 163.40% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 14.34 USD |
| 52 Week Low | 4.77 USD |
| 50-Day Moving Average | 10.07 USD |
| 200-Day Moving Average | 7.58 USD |
VYGR Share Statistics
| Avg. Volume (3 month) | 491.07K USD |
| Avg. Daily Volume (10-Days) | 535.62K USD |
| Shares Outstanding | 43.54M |
| Float | 22.81M |
| Short Ratio | 1.47 |
| % Held by Insiders | 23.75% |
| % Held by Institutions | 46.83% |
| Shares Short | 1.2M |
| Short % of Float | 3.47% |
| Short % of Shares Outstanding | 2.75% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 51.88% |
| Operating Margin (ttm) | 48.96% |
| Gross Margin | 65.92% |
| EBITDA Margin | 51.30% |
Management Effectiveness
| Return on Assets (ttm) | 20.83% |
| Return on Equity (ttm) | 67.57% |
Income Statement
| Revenue (ttm) | 190.73M USD |
| Revenue Per Share (ttm) | 4.89 USD |
| Quarterly Revenue Growth (yoy) | 22769.30% |
| Gross Profit (ttm) | -19857000 USD |
| EBITDA | 97.85M USD |
| Net Income Avi to Common (ttm) | 98.96M USD |
| Diluted EPS (ttm) | 2.24 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 273.31M USD |
| Total Cash Per Share (mrq) | 6.28 USD |
| Total Debt (mrq) | 22.44M USD |
| Total Debt/Equity (mrq) | 10.34 USD |
| Current Ratio (mrq) | 15.178 |
| Book Value Per Share (mrq) | 4.995 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 76.63M USD |
| Levered Free Cash Flow (ttm) | -34956876 USD |
Profile of Voyager Therapeutics
| Country | United States |
| State | MA |
| City | Cambridge |
| Address | 64 Sidney Street |
| ZIP | 02139 |
| Phone | 857 259 5340 |
| Website | https://www.voyagertherapeutics.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 125 |
Voyager Therapeutics, Inc., a biotechnology company, focuses on the treatment of gene therapy and neurology diseases. The company's lead clinical candidate is VY-TAU01, an anti-tau antibody program for the treatment of Alzheimer's disease. It also develops VY-FXN01 to treat Friedreich's ataxia; superoxide dismutase 1 gene silencing program for the treatment of amyotrophic lateral sclerosis; and GBA1 gene replacement program to treat Parkinson's disease. In addition, the company develops research program for the treatment of Huntington's disease. It has collaboration and license agreements with Neurocrine Biosciences, Inc.; Pfizer Inc.; and Novartis Pharma, A.G. for the research, development, and commercialization of adeno-associated virus gene therapy products. Voyager Therapeutics, Inc. was incorporated in 2013 and is headquartered in Cambridge, Massachusetts.
Q&A For Voyager Therapeutics Stock
What is a current VYGR stock price?
Voyager Therapeutics VYGR stock price today per share is 3.53 USD.
How to purchase Voyager Therapeutics stock?
You can buy VYGR shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Voyager Therapeutics?
The stock symbol or ticker of Voyager Therapeutics is VYGR.
Which industry does the Voyager Therapeutics company belong to?
The Voyager Therapeutics industry is Biotechnology.
How many shares does Voyager Therapeutics have in circulation?
The max supply of Voyager Therapeutics shares is 55.31M.
What is Voyager Therapeutics Price to Earnings Ratio (PE Ratio)?
Voyager Therapeutics PE Ratio is now.
What was Voyager Therapeutics earnings per share over the trailing 12 months (TTM)?
Voyager Therapeutics EPS is -1.13 USD over the trailing 12 months.
Which sector does the Voyager Therapeutics company belong to?
The Voyager Therapeutics sector is Healthcare.
Voyager Therapeutics VYGR included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17366.13 USD — |
-0.1
|
9.58B USD — | 17128.71 USD — | 17467.35 USD — | — - | 9.58B USD — |
| NASDAQ Global Select Market Com NQGS | 8495.19 USD — |
-0.11
|
— — | 8378.66 USD — | 8543.96 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 931.02 USD — |
+0.81
|
— — | 921.75 USD — | 934.48 USD — | — - | — — |
- {{ link.label }} {{link}}